Decently

Liverpool, United Kingdom Founded: 2021 • Age: 5 yrs
AI-based risk prediction platform for patient health is provided.
Annual revenue - Latest available
Total funding $619,390 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About Decently

Decently is a company based in Liverpool (United Kingdom) founded in 2021 by James Burch and James Chapman. Decently has raised $619.39 thousand across 1 funding round from investors including Praetura Ventures and SFC Capital. Decently offers products and services including Melo. Decently operates in a competitive market with competitors including BaseHealth, Advance Health, Peach IntelliHealth, PeraHealth and ToLife, among others.

  • Headquarter Liverpool, United Kingdom
  • Founders James Burch, James Chapman
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Decently Limited
  • Date of Incorporation 06 Sep, 2021
  • Jurisdiction MANCHESTER, ENGLAND
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$34.69 K (USD)
    0
    as on Dec 31, 2022
  • EBITDA
    Not available
  • Total Equity Funding
    $619.39 K (USD)

    in 1 rounds

  • Latest Funding Round
    $619.39 K (USD), Seed

    Sep 20, 2023

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Decently

Decently offers a comprehensive portfolio of products and services, including Melo.

Product name locked
Category locked
Primary

Platform for clinicians to analyze and understand patient behaviour.

Funding Insights of Decently

Decently has successfully raised a total of $619.39K through 1 strategic funding round. The most recent funding activity was a Seed round of $619.39 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Decently

Decently has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Praetura Ventures and SFC Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital funding is provided by Praetura Ventures.
Locked Locked Locked
Introductions between investors and early-stage companies are facilitated for funding.
Locked Locked Locked
Premium access

Investor details for Decently

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Decently

Investments
Premium access

Investment portfolio details for Decently

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Decently

Premium access

Detailed financials for Decently

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Decently Comparisons

Decently Primary company
Description
AI-based risk prediction platform for patient health is prov...
Location
Liverpool, United Kingdom
Founded Year
2021
Annual Revenue
Not available
Net Profit
-$34.69 K (USD)
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Decently

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Decently

Decently operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BaseHealth, Advance Health, Peach IntelliHealth, PeraHealth and ToLife, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genomics-driven personalized health risks and recommendations are provided.
Locked Locked Locked
Provider of health risk assessments and care management solutions for providers
Locked Locked Locked
An AI-based platform is provided to predict patient trajectories.
Locked Locked Locked
Patient conditions are tracked in real-time for hospital care applications.
Locked Locked Locked
Emergency care management software is provided for hospitals.
Locked Locked Locked
AI-based disease prediction is offered to healthcare professionals.
Premium access

Detailed competitors of Decently

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Decently

Premium access

Complete news archive for Decently

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Decently

Decently was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Decently is headquartered in Liverpool, United Kingdom.

Decently is a funded company, having raised a total of $619.39K across 1 funding round to date.

Decently was founded in 2021 and is based in Liverpool, United Kingdom. An AI-driven platform for predicting patient health risks is offered within the healthcare sector. Day-to-day changes in patient behavior, mood, and activity are tracked through smart analytics. Real-time dashboards, reporting tools, team communication features, and compliance support are included in the operations.

Decently's top competitors include UCARE.AI, BaseHealth and RetinaRisk.

Decently offers Melo.

Decently has 2 investors. Key investors include Praetura Ventures, and SFC Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available